Staking Our Claim Staking Our Claim

Staking Our Claim

Reaching New Destinations

Pliant Therapeutics is a clinical-stage biopharmaceutical company leading the way in developing new treatments for fibrotic diseases. As fibrosis is a complex disease, few available treatments for fibrosis exist today. We are committed to advancing novel treatments and prepared to change the fibrosis treatment landscape.

Pliant is diving deep to understand the molecular drivers of fibrotic diseases to unlock potentially safer, and more effective therapies for patients.

pliant workers

Vision, and
Core Values


Build the leading fibrosis company by combining world class expertise in fibrosis-biology, chemistry and technology to develop best-in-class, tissue-specific, inhibitors of fibrotic diseases.


Transform the lives of patients who suffer from debilitating and deadly fibrotic diseases.

Core Values

On our journey to change outcomes for patients with fibrotic diseases, we are guided by the following principles.

For Our Patients

We listen and learn from you. We embrace the challenge of curing fibrotic diseases. We foster innovation and science. We are true to the data and act with integrity.

For Our Team

We treat each other with respect. We are responsible for our actions. We communicate transparently and honestly. We build and cultivate a collaborative spirit.

A man and woman is talking

Our Team

Pliant is led by a team of world-renowned fibrosis researchers and highly experienced drug developers focused on translating science into novel therapies for patients in need.

Our Responsibility

While patients are at the center of our corporate responsibility efforts, we recognize that operating in a sustainable manner benefits all of our stakeholders, including employees, investors, environment, communities, and the patients we seek to serve. In that regard, we have undertaken various environmental, social and governance (“ESG”) initiatives, including in the areas of: environmental sustainability; access to our investigational therapies; continuing education and support; inclusion, diversity and development of our team; charitable contributions; and commitment to compliance and ethical business conduct.

We’re Here for Hope

General Contact

[email protected]

IR & Media Contact

Christopher Keenan
Pliant Therapeutics
Vice President, Investor Relations and Corporate Communications
[email protected]

HR Contact

[email protected]

331 Oyster Point Blvd
South San Francisco, CA 94080